- Home
- VTYX vs SEVN Comparison
VTYX vs SEVN Comparison
Compare VTYX & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- SEVN
- Stock Information
- Founded
- VTYX 2018
- SEVN 1986
- Country
- VTYX United States
- SEVN United States
- Employees
- VTYX N/A
- SEVN N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- SEVN Real Estate Investment Trusts
- Sector
- VTYX Health Care
- SEVN Real Estate
- Exchange
- VTYX Nasdaq
- SEVN Nasdaq
- Market Cap
- VTYX 154.9M
- SEVN 179.3M
- IPO Year
- VTYX 2021
- SEVN N/A
- Fundamental
- Price
- VTYX $2.79
- SEVN $11.13
- Analyst Decision
- VTYX Buy
- SEVN Strong Buy
- Analyst Count
- VTYX 4
- SEVN 3
- Target Price
- VTYX $11.33
- SEVN $14.75
- AVG Volume (30 Days)
- VTYX 2.0M
- SEVN 64.6K
- Earning Date
- VTYX 08-07-2025
- SEVN 07-28-2025
- Dividend Yield
- VTYX N/A
- SEVN 12.43%
- EPS Growth
- VTYX N/A
- SEVN N/A
- EPS
- VTYX N/A
- SEVN 1.15
- Revenue
- VTYX N/A
- SEVN $30,074,000.00
- Revenue This Year
- VTYX N/A
- SEVN $7.45
- Revenue Next Year
- VTYX N/A
- SEVN $1.12
- P/E Ratio
- VTYX N/A
- SEVN $9.71
- Revenue Growth
- VTYX N/A
- SEVN N/A
- 52 Week Low
- VTYX $0.78
- SEVN $10.18
- 52 Week High
- VTYX $3.39
- SEVN $14.66
- Technical
- Relative Strength Index (RSI)
- VTYX 62.76
- SEVN 45.10
- Support Level
- VTYX $1.95
- SEVN $12.40
- Resistance Level
- VTYX $2.51
- SEVN $12.76
- Average True Range (ATR)
- VTYX 0.17
- SEVN 0.33
- MACD
- VTYX -0.02
- SEVN 0.02
- Stochastic Oscillator
- VTYX 104.37
- SEVN 15.30
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.